To include your compound in the COVID-19 Resource Center, submit it here.

Off-label guess trips up Ligand

Although off-label use of a drug may significantly contribute to the product's sales, quantifying that contribution can be challenging. Ligand Pharmaceuticals Inc. last week illustrated that point, as the company lowered second quarter guidance in part

Read the full 366 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury


Article Purchase

This article may not be distributed to non-subscribers